Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects — Stella

Home/IBD (Inflammatory Bowel Disease)/ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

View on ClinicalTrials.gov

Recruiting

Back to IBD (Inflammatory Bowel Disease) trials

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

Trial locations(1 site)

United States

ALPCO, Salem, New Hampshire

Key details

Sponsor

American Laboratory Products Company

Enrollment target

~120 participants

Started

July 2025

Primary completion

October 2026

Age range

22 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.